Taipei, December 11, 2025: Dimerco Express Group ("Dimerco") has announced that it is strengthening its integrated, Asia-focused logistics solutions to help customers capture growth from AI and "Taiwan+, China+" manufacturing while managing risks from congestion, regulatory changes and shifting capacity

At COMPUTEX 2025, ASUS showcased its comprehensive AI infrastructure solutions, targeting the computing needs of data centers, edge computing, and a wide range of intelligent applications. With a robust product portfolio, ASUS brings to life the NVIDIA AI Factory vision, illustrating how AI will be deeply embedded into enterprise IT infrastructure. This evolution continues to drive forward applications and services that shape the future of AI and high-performance computing

Technology news, product launches and show highlights from the event attendees available for download (PDF).

Cancer is no longer considered untreatable, yet improving the accuracy and timeliness of diagnostics and treatment remains one of the most pressing challenges in clinical practice. Traditional cancer detection methods carry inherent limitations: tissue biopsies are highly invasive, causing discomfort and risk for patients, while blood-based biochemical tumor markers often lack specificity and fail to clearly differentiate between pathological signals and normal physiological fluctuations. As a result, liquid biopsy - valued for its safety, convenience, and ability to complement traditional pathology - has rapidly emerged as a global trend in cancer diagnostics.Developed by CytoAurora and distributed and supported by HUA TEC International, the Nano CAST AI semiconductor liquid tumor imaging system integrates semiconductor processes, AI imaging analysis, optical engineering, molecular pathology, and precision mechanics. The next-generation cancer cell detection platform will officially make its public debut at CES 2026, drawing significant attention from both medical and semiconductor communities.Chung-Er Huang, Chairman of HUA TEC International, noted that CytoAurora has long focused on single-cell biotechnology and device development, offering highly accurate solutions for genomic and protein-level analysis. To support the specialized needs of medical equipment deployment - installation, training, and maintenance - HUA TEC was established to lead Nano CAST's commercialization and technical support, helping hospitals and health examination centers rapidly adopt the system. The platform is already in clinical use at institutions such as Tzu Chi Hospital and Taipei Tzu Chi Hospital.According to Chien-Hsiang Tang, Vice President of HUA TEC International, Nano CAST utilizes semiconductor wafer-level surface modification to efficiently capture target cells circulating in the bloodstream. The system integrates precision mechanics and optical modules to automate cell capture, staining, and imaging. AI-driven image analysis then identifies and differentiates cancer cells from other cell types, enabling clinicians to execute targeted cell isolation, image interpretation, and downstream diagnostic analysis directly from blood samples.Nano CAST Supports the Full Cancer Care CycleAs semiconductor processes continue to advance, complex biochemical analyses that once required large laboratory setups can now be executed through highly integrated semiconductor biochips - making real-time testing more accessible and scalable. While genomic sequencing remains the most common application of such semiconductor-enabled medical technologies, HUA TEC is one of the few Taiwanese companies to extend semiconductor-based diagnostics into protein and biomarker analysis, particularly demonstrating strong breakthroughs in the field of liquid biopsy for oncology.Huang explained that Nano CAST is built upon two core components: the Cell Reveal Series and the CMS 200. The Cell Reveal Series uses semiconductor biochip technology to isolate specific or abnormal cells, forming nanoscale structures through plasma treatment, etching, and chemical modification that significantly enhance cell capture efficiency. The CMS 200 serves as the AI-driven imaging system that rapidly and objectively interprets captured cell and tissue images.Together, the system covers the complete clinical pathway of cancer care - from early detection of rare circulating tumor cells in blood, to monitoring treatment response, to identifying minimal residual disease (MRD) after therapy. By providing clinicians with earlier, more precise, and more actionable insights into disease progression, Nano CAST strengthens decision-making across the continuum of cancer management.TTA's High-Impact Global Pavilion Strategy Helps Drive Expansion into Central Asia, Europe, and the USAfter achieving notable milestones in Taiwan and obtaining BSI ISO 13485:2016 certification for medical device quality management, HUA TEC has accelerated its international expansion in recent years, establishing a presence in Thailand, Singapore, Japan, and Hong Kong. The company plans to further extend its footprint into Central Asia in 2026 as part of its broader global medical collaboration strategy.Huang emphasized that HUA TEC's consecutive participation in CES is driven by the strong curatorial and matchmaking capabilities of Taiwan Tech Arena (TTA). TTA's expertise in pavilion design, international outreach, and cross-border business facilitation significantly elevates the global visibility of Taiwanese startups. This enables companies such as HUA TEC to directly engage with major medical distributors, technology corporations, and investment groups across Europe and the United States, accelerating their path to market adoption.He stressed that Nano CAST demonstrates proven clinical performance, verifiable technical foundations, and scalability for commercial manufacturing - making CES the most important launchpad for HUA TEC's entry into the US and European markets. Through CES, the company aims to pursue strategic partnerships, initiate local clinical validations, and expand cross-border commercial activities, ultimately establishing a solid international presence. HUA TEC seeks to ensure that Taiwan's advanced semiconductor-enabled liquid biopsy technologies gain broader adoption across global clinical settings.The Nano CAST Cancer Solution for cancer cell detection. Credit: HUA TEC

Luna, the rapidly rising health-tech company redefining human performance, today unveiled the Luna Band, a groundbreaking new wearable designed to deliver real-time, voice-led health guidance. Powered by LifeOS, Luna's adaptive AI engine, the Luna Band represents a new category of personal health technology focused not on displaying data, but on providing timely, actionable guidance."In a market saturated with devices that simply report numbers and do analytics, Luna Band introduces a radically different philosophy: guidance over data"said the company's spokespersonBuilt around Luna's core pillars of biomarker intelligence, circadian rhythm, women's health, personal context, and 24/7 AI coaching, the Luna Band brings the full power of LifeOS to the wrist. With no monthly fees, the Band is positioned to democratize high-end health intelligence globally.A Voice-Led, Hands-Free Health ExperienceIn a first for any wearable, Luna band introduces fully hands-free, voice-led interactions, powered by Siri integrations. With Luna's dynamic logging, users can log meals, symptoms, emotional context, and request health guidance entirely through voice-input without even opening the Luna app. By allowing natural, conversational interaction through any earbuds or a connected device, Luna Band advances Luna's vision of a deeply integrated, ecosystem-agnostic LifeOS that works across devices and platforms.Advanced Biosensing for a New Level of PrecisionThe Luna Band features a research-grade optical sensor array paired with a high-fidelity 6-axis IMU. This sensing platform captures detailed physiological information associated with micro-recovery periods, circadian fluctuation, emotional stress signatures, and other subtle patterns that conventional consumer wearables often do not detect. This level of precision enables more informed and responsive health guidance.LifeOS: Real-Time Interpretation and Adaptive CoachingAt the core of the Luna Band is LifeOS, a real-time adaptive engine that processes thousands of physiological signals per minute. LifeOS identifies changes in recovery, stress, circadian alignment, and hormonal patterns, delivering context-aware recommendations throughout the day. The system is designed to offer timely support, ensuring users receive guidance at moments of highest relevance.Unified Health Ecosystem IntegrationLuna Band and Luna Ring serve as Luna's primary high-fidelity data collectors. But LifeOS also seamlessly integrates biomarker and usage data from Apple Health, Google Fit, Clue, Kindbody, and additional ecosystem partners to create a unified, longitudinal view of health. By integrating sleep, menstrual cycles, activity, stress, nutrition, and emotional inputs into a single framework, the Luna Band provides a comprehensive understanding of the user's daily physiological state.Redefining the Role of the WearableThe Luna Band establishes a new class of wearable technology centered on real-time guidance rather than retrospective reporting. By combining advanced sensing, adaptive intelligence, hands-free interaction, and broad ecosystem integration, Luna delivers a continuous health companion designed to support informed decision-making throughout the day, without subscription fees.Luna Band will be unveiled at Pepcom on 5th January 2026. CES attendees can see Luna Band firsthand at 55623, Venetian A-D Hall.

The High Technology Park of the Kyrgyz Republic (HTP) will participate in CES 2026, presenting the country's growing strength in artificial intelligence, digital health, blockchain technologies, and large-scale IT exports for global markets. At Booth 50265, the Kyrgyz delegation will showcase technology companies delivering AI products, telemedicine platforms, blockchain infrastructure, and software development services for clients worldwide.The Kyrgyz Republic has become one of the fastest-growing technology exporters in its region. In 2024, Kyrgyz IT specialists provided services to clients in more than 63 countries, generating $130 million in IT exports. The United States ranked first, accounting for around 40 percent of total exports, with an export volume exceeding $50 million, including cooperation with companies in Silicon Valley. Over the past five years, the country's IT exports have grown 45-fold, marking a structural shift toward high-value digital services and proprietary technology development. HTP now brings together a network of 500 software development companies and 3,000 developers, ready to meet the full range of client needs.Among the technologies presented at CES 2026 is KaniTTS, an open-source text-to-speech model developed by the AI startup NineNineSix. KaniTTS redefines real-time, human-like voice generation, matching the performance of leading commercial voice models while remaining fully open and free under the Apache 2.0 license. Since its release, KaniTTS has been downloaded more than 15,000 times on Hugging Face, drawing international attention for its speed, expressivity, and accessibility. The model is capable of generating 15 seconds of natural speech in just one second on a consumer-grade NVIDIA RTX 5080 GPU, enabling true real-time performance without cloud-scale infrastructure. The base model currently supports eight languages: English, German, Korean, Arabic, Chinese, Spanish, Kyrgyz, and Japanese.In parallel, NineNineSix together with HTP has released Kyrgyz Whisper, an open-source automatic speech recognition model fine-tuned on Whisper to deliver native speech recognition for Kyrgyz, Russian, and English. Performance highlights include a dramatic improvement in Kyrgyz word error rate from approximately 100 percent to 0.2 WER, while maintaining stable performance in English and Russian. Two model variants are available, a small version with 0.2 billion parameters and a medium version with 0.8 billion parameters, both supporting LoRA fine-tuning for domain adaptation and further improvements.The Kyrgyz delegation also includes Blockchain Data, a blockchain technology company developing digital infrastructure and crypto-related solutions. The Kyrgyz Republic has recently completed a major milestone in the digital finance sector with the launch of its national stablecoin, KGST, pegged 1:1 to the Kyrgyz som. KGST complies with international KYC/AML standards, features multi-level authentication, and has completed technical testing for deployment on both regional and global crypto platforms. According to the Chainalysis Global Crypto Adoption Index, the Kyrgyz Republic ranks 19th globally in cryptocurrency usage, reflecting an active, regulated, and rapidly developing crypto ecosystem.Digital health innovation will also be represented through Hi Doctor, an AI-powered telemedicine and clinical decision-support platform founded by diagnostic physician Nursultan Masalbekov. The product emerged from real clinical practice, where the lack of digital tools forced doctors to spend excessive time on documentation instead of patient care. Hi Doctor combines AI-driven analysis of clinical data, a voice assistant for medical documentation, and telemedicine tools, including NORAi, which analyzes patients' vital signs during video consultations. The platform is actively used by doctors and medical institutions across Kyrgyzstan and Kazakhstan. In multiple cases, AI-supported recommendations contributed to the early detection of HIV, cardiomyopathies, oncological and genetic conditions, later confirmed through laboratory testing, demonstrating the platform's real clinical impact.The Kyrgyz Republic invites attendees to meet its delegation at CES 2026 at the High Technology Park of the Kyrgyz Republic, Booth 50265, from January 6 to 9, 2026, in Las Vegas, Nevada.